Macleods Pharma USA Recalls 1,315 Levothyroxine 150 mcg Tablets (2026)
Macleods Pharma USA, Inc. recalls 1,315 bottles of Levothyroxine Sodium Tablets USP 150 mcg distributed nationwide. The drug is subpotent, which may not provide the full therapeutic dose. Stop using and contact your healthcare provider or Macleods Pharma USA, Inc. for guidance.
Product Details
Levothyroxine Sodium Tablets USP 150 mcg, 1000-tablet bottle. Rx Only. NDC 33342-401-44. Manufactured for Macleods Pharma USA, Inc., Princeton, NJ. Manufactured by Macleods Pharmaceuticals Ltd., Sarigam, Valsad, Gujarat, India. Lot 16240062A. Exp 3/2026. Quantity: 1315 bottles. Distributed nationwide.
The Hazard
The product is subpotent, meaning it may deliver less than the labeled dose. Inadequate thyroid hormone replacement can lead to under-treatment of hypothyroidism.
Reported Incidents
No injuries or incidents have been reported.
What to Do
1. Stop using the product. 2. Check the bottle for Lot 16240062A and Exp 3/2026. 3. Contact Macleods Pharma USA, Inc. or your healthcare provider for guidance. 4. Do not dispose of the product until advised. 5. If you experience symptoms of hypothyroidism, contact your clinician promptly.
Contact Information
FDA recall page: https://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?recall_number=D-0403-2026. For guidance, contact Macleods Pharma USA, Inc. directly or your healthcare provider.